Chemical Structure : Veliparib dihydrochloride
CAS No.: 912445-05-7
Catalog No.: PC-42353Not For Human Use, Lab Use Only.
Veliparib (ABT-888) dihydrochloride is a potent, BBB penetrant, and orally active PARP inhibitor with IC50 of 5.2 and 2.9 nM for PARP-1 and PARP-2, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
25 mg | $128 | In stock | |
50 mg | $198 | In stock | |
100 mg | $298 | In stock | |
250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Veliparib (ABT-888) dihydrochloride is a potent, BBB penetrant, and orally active PARP inhibitor with IC50 of 5.2 and 2.9 nM for PARP-1 and PARP-2, respectively.
Veliparib (ABT-888) displays no activity against SIRT2 and selective biochemical profile in a panel of 74 receptor-binding assays.
Veliparib (ABT-888) strongly potentiates temozolomide in the B16F10 s.c. murine melanoma model, also potentiates temozolomide, platinums, cyclophosphamide, and radiation in syngeneic and xenograft tumor models.
M.Wt | 317.2142 | |
Formula | C13H18Cl2N4O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 3.2 mg/mL |
|
Chemical Name/SMILES |
1H-Benzimidazole-7-carboxamide, 2-[(2R)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2) |
1. Donawho CK, et al. Clin Cancer Res. 2007 May 1;13(9):2728-37.
2. Albert JM, et al. Clin Cancer Res. 2007 May 15;13(10):3033-42.
3. Liu X, et al. Mol Cancer Res. 2008 Oct;6(10):1621-9.
4. Palma JP, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2625-35.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright